Insulin glargine, recombinant Subcutaneous and Solifenacin Succinate
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Solifenacin Succinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: solifenacin
Brand name: VESIcare
Synonyms: Solifenacin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Solifenacin Tablets
- Insulin glargine, recombinant Subcutaneous-Soliqua
- Insulin glargine, recombinant Subcutaneous-Soliqua 100/33
- Insulin glargine, recombinant Subcutaneous-Soliris
- Insulin glargine, recombinant Subcutaneous-Solmara Patch
- Insulin glargine, recombinant Subcutaneous-Solodyn
- Solifenacin Succinate-Insulin glulisine
- Solifenacin Succinate-Insulin Glulisine (Cartridges and Pens)
- Solifenacin Succinate-Insulin Glulisine (Vials)
- Solifenacin Succinate-Insulin glulisine Subcutaneous
- Solifenacin Succinate-Insulin human inhaled Inhalation
- Solifenacin Succinate-Insulin human regular Injection